Company / Free Cash Flow per Share
Rani Therapeutics Holdings, Inc. Free Cash Flow per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1255.93
FY2025
5-year range
-$2057.05 / -$0.83
FY2021-FY2025
Trend
+38.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share returned to growth in FY2025 after 2 years of decline, reaching $-1255.93.
Based on SEC 10-K filings.
-1255.93 in FY2025.
Improved from $-1676.62 to $-1255.93 over the past 3 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow per share increased 38.9% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1255.93 | +38.9% |
| FY2024 | -$2057.05 | -22.7% |
| FY2022 | -$1676.62 | -202567.1% |
| FY2021 | -$0.83 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026